Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection
Clinical trial NCT03913195 · COMPLETED
Trial details
- NCT number
- NCT03913195
- Sponsor
- TaiMed Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2022-10-17
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.